One of the inflammatory heart diseases, viz. acute myocarditis, occurs due to cardiac cell death. How-ever, the molecular mechanism underlying cell death remains largely unexplored. In this study, we report that the down-regulation of KCNJ11, a central sub-unit of the ATP-sensitive potassium (KATP) channel plays a key role in the reduction of blood glucose, and is involved in apoptosis of cardiac cells. Using proteo-mics analysis of experimental autoimmune myocardi-tis (EAM), we show that the KCNJ11 level marked by decreased, whereas Camk2a expression increased sig-nificantly in EAM tissues by 16 and 20 days, com-pared to control tissues. Using 1H-MAS NMR we also show that glucose levels were slightly elevated in EAM tissues. In vitro assays using H9c2 cardiac cells re-vealed that both lipopolysaccharide (LPS) and high glucose treatment decreased cell viability, in which toxicity was attenuated by treatment with KATP pharmacological openers, but not by the KATP block-ers (Gli and 5-HD). Apoptosis induced by LPS or high glucose treatment was suppressed by Ca2+ chelator (BAPTA-AM) treatment. We found that KCNJ11 levels had decreased in cardiac cells by LPS or high glucose treatment, and siRNA-mediated knockdown of KCNJ11 expression further stimulated the LPS- or high glucose-induced apoptosis. Together, our results demonstrate first that KCNJ11 is down-regulated under inflammation and high glucose conditions and its inactivation facilitates cardiac cell apoptosis. We assume that down-regulation of KCNJ11 has an effect on the development of myocarditis.
|Number of pages||7|
|Publication status||Published - 2020 Oct 10|
- blood glucose lipopolysaccha-
- cardiac cells
ASJC Scopus subject areas